Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond Debbane currently holds 1,906,186 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond Debbane has been a net buyer of LXRX stock. They have purchased $124.0M and sold $0 worth of shares.
Raymond Debbane's most recent insider trade was on Feb 25, 2026, when they purchased 2,000 shares at $1.49 per share.
Raymond Debbane serves as Executive at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have executed 169 insider transactions totaling $124.0M over their tenure at the company.
Raymond Debbane holds the position of Executive at LEXICON PHARMACEUTICALS, INC./DE, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Raymond Debbane has shown a buying trading pattern, with $124.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Raymond Debbane was on Aug 1, 2022, when they purchased $2.5M worth of LXRX shares. This transaction involved 982,600 shares at $2.50 per share.
Raymond Debbane currently owns 1,906,186 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond Debbane's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond Debbane has 169 Form 4 filings on record as an insider at LEXICON PHARMACEUTICALS, INC./DE.
Set alerts for Raymond Debbane and 40,000+ other insiders.